| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| PRKCA |
Heptanoic acid (2S,3R)-2-hydroxymethyl-5-oxo-tetrahydro-furan-3-yl ester |
187000 |
NA |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PRKCA |
2-[[2,6-Dihydroxy-4-[4-[(4-hydroxybenzoyl)amino]pyrrolidin-3-yl]oxycarbonylbenzoyl]amino]benzoic acid |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
(1S)-2-[2,6-dihydroxy-4-[(4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]cyclohexane-1-carboxylic acid |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
8-hydroxy-6-[(4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonyl-9-oxoxanthene-1-carboxylic acid |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
(1R)-2-[2,6-dihydroxy-4-[(4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl]oxycarbonylbenzoyl]cyclohexane-1-carboxylic acid |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
[(4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl] 4-(2,6-dihydroxybenzoyl)-3,5-dimethoxybenzoate |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
2-(N-[2,6-dihydroxy-4-[4-[(4-hydroxybenzoyl)amino]pyrrolidin-3-yl]oxycarbonylbenzoyl]anilino)acetic acid |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
[(4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl] 3,5-dihydroxy-4-(1-hydroxynaphthalene-2-carbonyl)benzoate |
NA |
150000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
4-amino-5-[5-[[4-(1H-indol-2-yl)-2,5-dioxopyrrol-3-yl]amino]pentylamino]-5-oxopentanoic acid |
NA |
105000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
3-[2-(2-aminoethylamino)ethylamino]-4-(1H-indol-2-yl)pyrrole-2,5-dione |
NA |
120000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
3-[5-(2-aminoethylamino)pentylamino]-4-(1H-indol-2-yl)pyrrole-2,5-dione |
NA |
110000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
2-amino-N-[5-[[4-(1H-indol-2-yl)-2,5-dioxopyrrol-3-yl]amino]pentyl]-3-phenylpropanamide |
NA |
120000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
3-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-13-(1,3-dihydroxypropan-2-ylamino)-6,20-dihydroxy-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione |
NA |
120000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
[6-(5,21-Dichloro-12,14-dioxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaen-3-yl)-4,5-dihydroxy-3-methoxyoxan-2-yl]methyl 2-bromoacetate |
NA |
101000 |
NA |
NA |
NA |
NA |
BindingDB |
| PRKCA |
Resveratrol |
NA |
NA |
NA |
5780000 |
NA |
NA |
BindingDB|PubChem|TTD |
| PRKCA |
AR-AO-14418 |
NA |
100000000 |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
4-Phenyl-[1]benzofuro[2,3-b]pyridine-3,6-diol |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| PRKCA |
Harmine |
NA |
250000 |
NA |
NA |
NA |
NA |
PubChem |
| PRKCA |
1-[(4-methoxyphenyl)methyl]-3-[6-(2H-tetrazol-5-yl)-1,3-benzothiazol-2-yl]urea |
NA |
24200000 |
NA |
NA |
NA |
NA |
BindingDB|TTD |
| PRKCA |
1-[(4-methoxyphenyl)methyl]-3-[4-(2H-tetrazol-5-yl)pyridin-2-yl]urea |
NA |
100000000 |
NA |
NA |
NA |
NA |
TTD |